These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18460771)

  • 1. 5-HT2A receptor gene polymorphism and negative symptoms in first episode (drug-naive) Chinese Han nationality individuals with schizophrenia.
    Wang YH; Li WQ; Huang Z; Shi YZ; Wang XY; Huang JS; Zhou XH; Chen HX; Hao W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Apr; 33(4):293-8. PubMed ID: 18460771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics of treatment in first-episode schizophrenia: D3 and 5-HT2C receptor polymorphisms separately associate with positive and negative symptom response.
    Reynolds GP; Yao Z; Zhang X; Sun J; Zhang Z
    Eur Neuropsychopharmacol; 2005 Mar; 15(2):143-51. PubMed ID: 15695058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensorimotor gating of schizophrenia patients is influenced by 5-HT2A receptor polymorphisms.
    Quednow BB; Kühn KU; Mössner R; Schwab SG; Schuhmacher A; Maier W; Wagner M
    Biol Psychiatry; 2008 Sep; 64(5):434-7. PubMed ID: 18420180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetic polymorphism of the PRODH and 5-HT(2A) receptor gene in Korean-Chinese and Han nationality in Chinese Yanbian area].
    Jiang WK; Xu QS; Piao YQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):93-5. PubMed ID: 18247315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risperidone-related weight gain: genetic and nongenetic predictors.
    Lane HY; Liu YC; Huang CL; Chang YC; Wu PL; Lu CT; Chang WH
    J Clin Psychopharmacol; 2006 Apr; 26(2):128-34. PubMed ID: 16633140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between the T102C polymorphism of the serotonin-2A receptor gene and schizophrenia.
    Vaquero Lorenzo C; Baca-Garcia E; Diaz-Hernandez M; Botillo-Martin C; Perez-Rodriguez MM; Fernandez-Ramos C; Saiz-Gonzalez MD; Quintero-Gutierrez FJ; Saiz-Ruiz J; Fernandez Piqueras J; Gonzalez de Rivera JL; de Leon J
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1136-8. PubMed ID: 16762472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T102C polymorphism of the 5-HT2A receptor gene may be associated with temporomandibular dysfunction.
    Mutlu N; Erdal ME; Herken H; Oz G; Bayazit YA
    Oral Dis; 2004 Nov; 10(6):349-52. PubMed ID: 15533210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative symptoms of schizophrenia could explain discrepant data on the association between the 5-HT2A receptor gene and response to antipsychotics.
    Hamdani N; Bonnière M; Adès J; Hamon M; Boni C; Gorwood P
    Neurosci Lett; 2005 Mar; 377(1):69-74. PubMed ID: 15722190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [No association of -1438G/A polymorphism in promoter region of 5-HT2A receptor gene with antipsychotic agent-induced weight gain].
    Mou XD; Zhang ZJ; Yao ZJ; Liu W; Zhang XR; Shi JB; Sun J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Oct; 22(5):575-6. PubMed ID: 16215954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No association of antipsychotic agent-induced weight gain with a DA receptor gene polymorphism and therapeutic response.
    Zhang ZJ; Yao ZJ; Zhang XB; Chen JF; Sun J; Yao H; Hou G; Zhang XB
    Acta Pharmacol Sin; 2003 Mar; 24(3):235-40. PubMed ID: 12617772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No association or linkage between the 5-HT2a/T102C polymorphism and schizophrenia in Irish families.
    Hawi Z; Myakishev MV; Straub RE; O'Neill A; Kendler KS; Walsh D; Gill M
    Am J Med Genet; 1997 Jul; 74(4):370-3. PubMed ID: 9259371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association of antipsychotic agent-induced weight gain with a polymorphism of the promotor region of the 5-HT2C receptor gene].
    Zhang Z; Zhang X; Yao Z; Chen J; Sun J; Yao H; Hou G; Zhang X; Reynolds GP
    Zhonghua Yi Xue Za Zhi; 2002 Aug; 82(16):1097-101. PubMed ID: 12425817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association study of serotonin 2A receptor (5-HT2A) and serotonin transporter (5-HTT) gene polymorphisms with schizophrenia.
    Sáiz PA; García-Portilla MP; Arango C; Morales B; Alvarez V; Coto E; Fernández JM; Bascarán MT; Bousoño M; Bobes J
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):741-5. PubMed ID: 17291660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No association of serotonin transporter polymorphism (5-HTTVNTR and 5-HTTLPR) with characteristics and treatment response to atypical antipsychotic agents in schizophrenic patients.
    Lee HY; Kim DJ; Lee HJ; Choi JE; Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):276-80. PubMed ID: 19059448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone in first-episode schizophrenia.
    Cesková E; Prikryl R; Kaspárek T
    Neuro Endocrinol Lett; 2007 Dec; 28(6):811-4. PubMed ID: 18063925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin-2A receptor gene T102C polymorphism in patients with dyspeptic symptoms.
    Tahara T; Arisawa T; Shibata T; Nakamura M; Wang F; Hirata I; Nakano H
    Hepatogastroenterology; 2008; 55(86-87):1921-4. PubMed ID: 19102423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dopamine D2 receptor Ser311Cys polymorphism and clinical factors on risperidone efficacy for positive and negative symptoms and social function.
    Lane HY; Lee CC; Chang YC; Lu CT; Huang CH; Chang WH
    Int J Neuropsychopharmacol; 2004 Dec; 7(4):461-70. PubMed ID: 15140279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin-2A receptor gene is not associated with symptomatology of schizophrenia.
    Serretti A; Cusin C; Lorenzi C; Lattuada E; Lilli R; Smeraldi E
    Am J Med Genet; 2000 Feb; 96(1):84-7. PubMed ID: 10686558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emotional management and 5-HT2A receptor gene variance in patients with schizophrenia.
    Lo CH; Tsai GE; Liao CH; Wang MY; Chang JP; Tsuang HC; Lane HY
    Biol Psychol; 2010 Feb; 83(2):79-83. PubMed ID: 19913072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delusion symptoms and response to antipsychotic treatment are associated with the 5-HT2A receptor polymorphism (102T/C) in Alzheimer's disease: a 3-year follow-up longitudinal study.
    Angelucci F; Bernardini S; Gravina P; Bellincampi L; Trequattrini A; Di Iulio F; Vanni D; Federici G; Caltagirone C; Bossù P; Spalletta G
    J Alzheimers Dis; 2009; 17(1):203-11. PubMed ID: 19494443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.